Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 278

Iguazio includes corporates in $33m series B

Verizon Ventures, Robert Bosch Venture Capital, Dell Technologies Capital and CME Ventures all invested in the data analytics technology provider, which is valued at $100m.

Jul 26, 2017

Fosun clutches Teddy in series B round

Phone number recognition startup Teddy Mobile has now raised $29m in total, after securing an undisclosed amount in a round co-led by Fosun RZ Capital.

Jul 25, 2017

Goldman Sachs provides $35m to Beqom

The Swisscom-backed cloud-based compensation software provider has received $35m in funding from Goldman Sachs Private Capital Investing.

Jul 25, 2017

Pfizer helps expand Effector with series C funding

Pfizer Venture Investments led the small-molecule cancer drug developer's $38.6m series C round, which included Novartis, GlaxoSmithkline, AbbVie and Astellas.

Jul 25, 2017

Graphcore frames $30m series B

Robert Bosch Venture Capital, Samsung Catalyst Fund and Dell Technologies Capital backed an Atomico-led round that doubled the machine intelligence startup's total funding.

Jul 21, 2017

Dynamic Yield brings in extra series C funding

The personalised marketing technology producer has increased its series C to $31m, with Deutsche Telekom joining a round that already included Baidu.

Jul 21, 2017

Boston Medical helps pour series B funds into Amphora

Medical device developer Amphora Medical has closed a $35.5m series B round co-led by Boston Scientific that will fund a pivotal study for its OAB treatment.

Jul 21, 2017

Yissum-backed JII receives $25m

The Jerusalem Innovation Incubator is set to obtain $25m from Reliance Industries, which helped launch the project last month alongside Yissum and others.

Jul 21, 2017

Alation logs $23m in series B

The collaborative data platform has closed a series B round that comes two years after a Bloomberg Beta-backed series A.

Jul 19, 2017

PegBio clinches $20m in series E

Tasly Pharma has led a series E round for PegBio, which is working on drugs to treat diabetes and obesity, and which is also backed by Legend Holdings.

Jul 19, 2017
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here